These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23716545)

  • 1. Hypodiploid multiple myeloma is characterized by more aggressive molecular markers than non-hyperdiploid multiple myeloma.
    Van Wier S; Braggio E; Baker A; Ahmann G; Levy J; Carpten JD; Fonseca R
    Haematologica; 2013 Oct; 98(10):1586-92. PubMed ID: 23716545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additional-structural-chromosomal aberrations are associated with inferior clinical outcome in patients with hyperdiploid multiple myeloma: a single-institution experience.
    Carballo-Zarate AA; Medeiros LJ; Fang L; Shah JJ; Weber DM; Thomas SK; Manasanch EE; Hao S; Shen Q; Orlowski RZ; Lin P; Lu X
    Mod Pathol; 2017 Jun; 30(6):843-853. PubMed ID: 28281554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid cases.
    Smadja NV; Leroux D; Soulier J; Dumont S; Arnould C; Taviaux S; Taillemite JL; Bastard C
    Genes Chromosomes Cancer; 2003 Nov; 38(3):234-9. PubMed ID: 14506697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of cytogenetics and molecular profiling in multiple myeloma.
    Sawyer JR
    Cancer Genet; 2011 Jan; 204(1):3-12. PubMed ID: 21356186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotype and DNA content of myeloma cells in primary plasma cell leukemia.
    Shimazaki C; Gotoh H; Ashihara E; Oku N; Inaba T; Murakami S; Itoh K; Ura Y; Nakagawa M; Fujita N
    Am J Hematol; 1992 Mar; 39(3):159-62. PubMed ID: 1546712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is flow cytometric DNA content hypodiploidy prognostic in multiple myeloma?
    Greipp PR; Trendle MC; Leong T; Oken MM; Kay NE; Van Ness B; Kyle RA
    Leuk Lymphoma; 1999 Sep; 35(1-2):83-9. PubMed ID: 10512165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypodiploidy is a major prognostic factor in multiple myeloma.
    Smadja NV; Bastard C; Brigaudeau C; Leroux D; Fruchart C;
    Blood; 2001 Oct; 98(7):2229-38. PubMed ID: 11568011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes.
    Mohamed AN; Bentley G; Bonnett ML; Zonder J; Al-Katib A
    Am J Hematol; 2007 Dec; 82(12):1080-7. PubMed ID: 17654686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Masked hypodiploidy: Hypodiploid acute lymphoblastic leukemia (ALL) mimicking hyperdiploid ALL in children: A report from the Children's Oncology Group.
    Carroll AJ; Shago M; Mikhail FM; Raimondi SC; Hirsch BA; Loh ML; Raetz EA; Borowitz MJ; Wood BL; Maloney KW; Mattano LA; Larsen EC; Gastier-Foster J; Stonerock E; Ell D; Kahwash S; Devidas M; Harvey RC; Chen IL; Willman CL; Hunger SP; Winick NJ; Carroll WL; Rao KW; Heerema NA
    Cancer Genet; 2019 Oct; 238():62-68. PubMed ID: 31425927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperdiploidy is a common finding in monoclonal gammopathy of undetermined significance and monosomy 13 is restricted to these hyperdiploid patients.
    Brousseau M; Leleu X; Gerard J; Gastinne T; Godon A; Genevieve F; Dib M; Lai JL; Facon T; Zandecki M;
    Clin Cancer Res; 2007 Oct; 13(20):6026-31. PubMed ID: 17947464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and exploitation of hyperdiploid and non-hyperdiploid human myeloma cell lines.
    Li X; Pennisi A; Zhan F; Sawyer JR; Shaughnessy JD; Yaccoby S
    Br J Haematol; 2007 Sep; 138(6):802-11. PubMed ID: 17760811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of G banded karyotypes in myeloma cells.
    Chen KC; Bevan PC; Matthews JG
    J Clin Pathol; 1986 Mar; 39(3):260-6. PubMed ID: 3457025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of ITGA6 confers to the invasion of multiple myeloma and promotes progression to plasma cell leukaemia.
    Song S; Zhang J; Su Q; Zhang W; Jiang Y; Fan G; Qian C; Li B; Zhuang W
    Br J Cancer; 2021 May; 124(11):1843-1853. PubMed ID: 33785876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In multiple myeloma, circulating hyperdiploid B cells have clonotypic immunoglobulin heavy chain rearrangements and may mediate spread of disease.
    Pilarski LM; Giannakopoulos NV; Szczepek AJ; Masellis AM; Mant MJ; Belch AR
    Clin Cancer Res; 2000 Feb; 6(2):585-96. PubMed ID: 10690543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The shaping and functional consequences of the dosage effect landscape in multiple myeloma.
    Samur MK; Shah PK; Wang X; Minvielle S; Magrangeas F; Avet-Loiseau H; Munshi NC; Li C
    BMC Genomics; 2013 Oct; 14():672. PubMed ID: 24088394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of specific miRNAs in hyperdiploid multiple myeloma mimics the oncogenic effect of IgH translocations occurring in the non-hyperdiploid subtype.
    Rio-Machin A; Ferreira BI; Henry T; Gómez-López G; Agirre X; Alvarez S; Rodriguez-Perales S; Prosper F; Calasanz MJ; Martínez J; Fonseca R; Cigudosa JC
    Leukemia; 2013 Apr; 27(4):925-31. PubMed ID: 23174883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlations.
    Calasanz MJ; Cigudosa JC; Odero MD; Ferreira C; Ardanaz MT; Fraile A; Carrasco JL; Solé F; Cuesta B; Gullón A
    Genes Chromosomes Cancer; 1997 Feb; 18(2):84-93. PubMed ID: 9115968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytogenetic abnormalities in high-risk multiple myeloma].
    Ishida T
    Nihon Rinsho; 2015 Jan; 73(1):28-32. PubMed ID: 25626299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the true hyperdiploid multiple myeloma subset by combining conventional karyotyping and FISH analysis.
    Barilà G; Bonaldi L; Grassi A; Martines A; Liço A; Macrì N; Nalio S; Pavan L; Berno T; Branca A; Calabretto G; Carrino M; Teramo A; Manni S; Piazza F; Semenzato G; Zambello R
    Blood Cancer J; 2020 Feb; 10(2):18. PubMed ID: 32066724
    [No Abstract]   [Full Text] [Related]  

  • 20. Transcriptome analysis reveals significant differences between primary plasma cell leukemia and multiple myeloma even when sharing a similar genetic background.
    Rojas EA; Corchete LA; Mateos MV; García-Sanz R; Misiewicz-Krzeminska I; Gutiérrez NC
    Blood Cancer J; 2019 Nov; 9(12):90. PubMed ID: 31748515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.